Why randomized trials for proton therapy are difficult to complete (and what we can do about it)

(University of Pennsylvania School of Medicine) Commercial insurance medical policies that do not cover treatment with proton therapy can make it difficult for patients to participate in randomized clinical trials funded by the NCI, part of the National Institutes of Health, that are evaluating the therapy.

https://www.eurekalert.org/pub_releases/2018-07/uops-wrt071118.php

Source: EurekAlert! - Medicine and Health - July 11, 2018 Category: International Medicine & Public Health Source Type: news